These are representative strategic scenarios. They illustrate how Gabriel & Co thinks and works – they are not descriptions of specific client engagements, and any outcomes described are illustrative.

GPDA | MD Graduate
From Frustrated Fresher to Medical Affairs Professional

An MD in Pharmacology with strong credentials kept hearing the same rejection: insufficient industry experience. The problem was never the science. It was how the science was presented.

* Representative scenario - illustrative, not a client case study.

GPDA | PharmD Graduate
The PharmD Who Built Their Own Case

A PharmD graduate was told repeatedly that the degree was the wrong credential for Medical Affairs. The training was never the gap. The framework for presenting it was.

* Representative scenario - illustrative, not a client case study.

Consulting | Specialty Pharma
From Data Asset to Clinical Conversation

An oncology product with a robust dataset was losing share to a competitor with weaker science. Oncologists were receiving data points, not a clinical story.

* Representative scenario - illustrative, not a client case study.

Consulting | Big Pharma
When Medical Affairs Becomes Strategy, Not Support

A respected Medical Affairs team at an MNC's India affiliate was working hard, producing output, and absent from every brand planning discussion. What changed was not the effort.

* Representative scenario - illustrative, not a client case study.

MedTech Startup
From Seed Funding to a Market-Ready Scientific Story

A device startup had exceptional engineering and promising clinical data. Between proof of concept and hospital adoption sat a gap no one on the founding team was trained to cross.

* Representative scenario - illustrative, not a client case study.

Nutraceutical
Moving from Claims to Credibility

A metabolic health brand had strong consumer data and polite scepticism from every physician it approached. Prescriber confidence would not move until the question changed.

* Representative scenario - illustrative, not a client case study.

Product Strategy | New Product Launch
New Product Launch Excellence Strategy

Six months to launch, strong clinical data, and a Medical Affairs plan that amounted to a KOL list and a slide deck. The scientific story did not exist yet.

* Representative scenario - illustrative, not a client case study.

Evidence Strategy | Matured Product
Matured Product – Growth Strategy

Six years post-launch, flat growth, and a louder competitor. Nobody had asked what evidence was still missing, or what the existing evidence was failing to say.

* Representative scenario - illustrative, not a client case study.